Antimicrobial Resistance News and Research

RSS

Irish study to look at how bacteria, Yersinia enterocolitica, enters the food chain

Monitoring of pig carcasses and pig meat in slaughterhouses, butchers' premises and retail outlets will be undertaken in Ireland over the next two years in an attempt to determine how a human disease causing bacteria, Yersinia enterocolitica, enters the food chain, scientists announced today (Tuesday 4 September 2007) at the Society for General Microbiology's 161st Meeting at the University of Edinburgh, UK, which runs from 3-6 September 2007.

4 Sep 2007

Natural antimicrobial agents for food safety

Two items high on the list of public concerns are the need for greater food safety and a growing demand for natural or organic food products.

22 Aug 2007

Latest MRSA bloodstream infections and Clostridium difficile figures

Latest figures for MRSA show there was a 6.4% fall in the number of cases of blood stream infection reported to the Health Protection Agency from January - March 2007.

26 Jul 2007

GPs antibiotic prescribing practices are still contributing to resistance

GPs are still prescribing antibiotics for up to 80% of cases of sore throat, otitis media, upper respiratory tract infections, and sinusitis, despite the fact that official guidance warns against this practice, according to an analysis of the world's largest primary care database of consultations and prescriptions, published this week in a supplement to the Journal of Antimicrobial Chemotherapy.

26 Jul 2007

Community-associated antibiotic-resistant staph infections increase

The incidence of antibiotic-resistant staph infections associated with being acquired in the community and not in health care institutions increased almost seven-fold in Chicago's Cook County Hospital system between 2000 and 2005, according to a report in the Archives of Internal Medicine.

30 May 2007

Quarterly UK Clostridium difficile and MRSA figures

Latest figures from the Health Protection Agency show there were 55,681 cases of Clostridium difficile infection reported in patients aged 65 years and above in England in 2006.

27 Apr 2007

Clean hands save patient lives

Experts on patient safety are urging countries in Latin America and the Caribbean to join a global effort to improve hand hygiene and related practices in hospitals and health care facilities to help reduce the growing number of deaths and illnesses due to health care-associated infections.

5 Mar 2007

Global Patient Safety Challenge: Clean Care is Safer Care

Half the people in the world can look forward to cleaner and safer care and a lowered risk of becoming ill with an infection as a result of their health care.

13 Nov 2006

MRSA - surveillance, rapid screening and hospital hygiene

The origins and future perspectives about meticillin-resistant Staphylococcus aureus (MRSA) are outlined in a Review in this week's issue of The Lancet.

31 Aug 2006

No wonder Brits worry more about MRSA than waiting lists

Scientists say they believe as many as 53 million people may carry the superbug MRSA.

21 Jun 2006

Clinical decision support system reduces overall use of antimicrobials for colds, bronchitis and sinusitis

A clinical decision support system intervention reduced the overall use of antimicrobials for respiratory tract infections such as colds, bronchitis and sinusitis, according to a study in the JAMA: The Journal of the American Medical Association.

15 Nov 2005

Controlling antibiotic-prescribing practices in hospitals

Plenty of promising strategies exist to control antibiotic-prescribing practices, but no single method emerges as the best for hospital patients, according to a new review of studies.

18 Oct 2005

Infectious diseases pose a serious threat to the nation's public health

Infectious diseases pose a serious threat to the nation's public health. Today, experts addressed key developments to the current and future outlook of infectious diseases, highlighting adolescent immunizations, outbreaks and epidemics of infectious diseases, antimicrobial resistance and new developments in HIV medicine, at a press conference sponsored by the National Foundation for Infectious Diseases (NFID).

27 Jul 2005

Neonatal infections in hospital born babies are up to 20 times higher in developing countries

Neonatal deaths account for over one-third of the global burden of child mortality. Infections are the major cause of neonatal deaths in developing countries. (See The Lancet Neonatal Survival Series, March 2005) Data suggest that unhygienic practices in labour and delivery, and in after-birth care, put babies in the developing world at great risk of infections and death soon after birth.

28 Mar 2005

Antimicrobials improperly used about 50% of the time

Antimicrobial medications intended to prevent surgical site infections are appropriately administered to patients (within one hour before incision) only 55.7 percent of the time, according to a study published in the February issue of Archives of Surgery.

21 Feb 2005

Three-day antibiotic treatment for treating bladder infections in women

A three-day regimen of the antibiotic amoxicillin-clavulanate is not as effective as ciprofloxacin at treating an uncomplicated bladder infection in women, according to a study conducted by Thomas M. Hooton, M.D., of the University of Washington and Harborview Medical Center, Seattle, and colleagues.

21 Feb 2005

New rapid gonorrhea test that does not require collection

Potential antimicrobial resistance in the bacteria that cause gonorrhea can be detected without culturing the organism, thanks to a rapid test developed by researchers at Johns Hopkins.

1 Nov 2004

Patients with chronic rhinosinusitis do not necessarily develop resistance to antibiotics

Patients with chronic rhinosinusitis (CRS, inflammation of the nasal passages and sinuses) do not necessarily develop resistance to antibiotics although they may be treated for long periods of time with these drugs

18 Oct 2004

KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates

Results from an ongoing surveillance study, PROTEKT US (Prospective Resistant Organism Tracking and Epidemiology of the Ketolide Telithromycin – United States) Year 2 (2001-2002), suggest that KETEK® (telithromycin) is highly active in vitro against Streptococcus pneumoniae (S. pneumoniae) isolates, including those resistant to other antimicrobial agents.

24 May 2004